Ruthenium(VI) and osmium(VI) nitrido complexes with halogenated phenoxide and thiophenoxide ligands

Treatment of [Buⁿ₄N][Ru(N)Cl₄] with Na(OR) afforded [Buⁿ₄N][Ru(N)(OR)₄] (R = C₆F₅ (1), C₆F₄H (2), C₆Br₅ (3)), whereas that with [Buⁿ₄N][Os(N)Cl₄] gave [Buⁿ₄N][Os(N)(OR)₃Cl] (R = C₆F₅ (4), C₆F₄H (5), C₆Br₅ (6)). Treatment of [Buⁿ₄N][M(N)Cl₄] with Na(SC₆F₄H) and Na(Sxyl) (xyl = 2,6-dimethylphenyl) afforded [Buⁿ₄N][M(N)(SC₆F₄H)₄] (M = Ru (7), Os (8)) and [Buⁿ₄N][M(N)(Sxyl)₄] (M = Ru (9), Os (10)), respectively. The crystal structures of compounds 1, 6 and 9 have been determined.     

Novel dioxomolybdenum(VI) and oxomolybdenum(V) complexes with pyridoxal thiosemicarbazone ligands: Synthesis and structural characterisation

New molybdenum complexes were prepared by the reaction of [Mo^VIO₂(acac)₂] or (NH₄)₂[Mo^VOCl₅] with different N-substituted pyridoxal thiosemicarbazone ligands (H₂L¹ = pyridoxal 4-phenylthiosemicarbazone; H₂L² = pyridoxal 4-methylthiosemicarbazone, H₂L³ = pyridoxal thiosemicarbazone). The investigation of monomeric [MoO₂L¹(CH₃OH)] or polymeric [MoO₂L^1-3] molybdenum(VI) complexes revealed that molybdenum is coordinated with a tridentate doubly-deprotonated ligand. In the oxomolybdenum(V) complexes [MoOCl₂(HL^1-3)] the pyridoxal thiosemicarbazonato ligands are tridentate mono-deprotonated. Crystal and molecular structures of molybdenum(VI) [MoO₂L¹(CH₃OH)]·CH₃OH, and molybdenum(V) complexes [MoOCl₂(HL¹)]·C₂H₅OH, as well as of the pyridoxal thiosemicarbazone ligand methanol solvate H₂L³·MeOH, were determined by the single crystal X-ray diffraction method.     

Synthesis and reactivity of coordinatively unsaturated osmium and ruthenium stannyl complexes

Treatment of MHCl(CO)(PPh₃)₃ (M=Ru, Os) with (CH₂=CH)SnR₃ is a good general route to the coordinatively unsaturated osmium and ruthenium stannyl complexes M(SnR₃)Cl(CO)(PPh₃)₂ (1: M=Ru, R=Me; 2: M=Ru, R = n-butyl; 3: M=Ru, R = p-tolyl; 4: M=Os, R=Me). These coordinatively unsaturated complexes readily add CO and CN-p-tolyl to form the coordinatively saturated compounds M(SnR₃)Cl(CO)L(PPh₃)₂ (5: M=Ru, R=Me, L=CO; 6: M=;Ru, R = n-butyl, L=CO; 7: M=Ru, R = p-tolyl, L=CO; 8: M=Os, R=Me, L=CO; 9: M=Ru, R=Me, L=CN-p-tolyl; 10: M=Ru, R = n-butyl, L=CN-p-tolyl; 11: M=Os, R=Me, L=CN-p-tolyl). In addition, the chloride ligand in Ru(SnR₃)Cl(CO)(PPh₃)₂ proves to be labile and treatment with the potentially bidentate anionic ligands, dimethyldithiocarbamate or diethyldithiocarbamate, affords the coordinatively saturated compounds Ru(SnR₃)(η²-S₂CNR′₂)(CO)(PPh₃)₂ (12: R=Me, R′ = Me; 13: R=Me, R′ = Et; 14: R = n-butyl, R′ = Me; 15: R = p-tolyl, R′ = Me; 16: R = p-tolyl, R′ = Et). Chloride is also displaced by carboxylates forming the six-coordinate compounds Ru(SnR₃)(η²-O₂CR′)(CO)(PPh₃)₂ (17: R=Me, R′ = H; 18: R=Me, R′ = Me; 19: R=Me, R′ = Ph; 20: R = n-butyl, R′ = Me; 21: R = p-tolyl, R′ = Me). IR and ¹H NMR spectral data for all the new compounds and ³¹P and ¹¹⁹Sn NMR spectral data for selected compounds are reported.     

Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation

The interaction of the first-generation quinolone antibacterial drug oxolinic acid (Hoxo) with the dioxomolybdenum(VI) and dioxouranim(VI) ions leads to the formation of the neutral mononuclear complexes MoO₂(oxo)₂ and UO₂(oxo)₂, respectively. The structure of the complexes has been characterized physicochemically and spectroscopically. The lowest energy model structure of the complexes has been determined with molecular modeling calculations. The antimicrobial activity of the complexes has been evaluated against three different microorganisms. The interaction of the complexes with calf-thymus DNA has been investigated with electronic and circular dichroism spectroscopies.     

Diazo complexes of osmium: preparation of binuclear derivatives with bis(aryldiazene) and bis(aryldiazenido) bridging ligands

Depending on experimental conditions and the nature of the phosphite, the reaction of OsH₂P₄ [P=P(OEt)₃ and PPh(OEt)₂] with bis(aryldiazonium) salts [N₂Ar-ArN₂](BF₄)₂ [Ar-Ar=4,4^′-C₆H₄-C₆H₄, 4,4^′-(2-CH₃)C₆H₃-C₆H₃(2-CH₃), 4,4^′-C₆H₄-CH₂-C₆H₄ and 1,5-C₁₀H₆] afford the cis and the trans binuclear [{OsHP₄}₂(μ-HNNAr-ArNNH)](BPh₄)₂1, 2 aryldiazene derivatives. These complexes 1, 2 further react with the mono(diazonium) (4-CH₃C₆H₄N₂)BF₄ salt to give the bis(aryldiazene) [{Os(4-CH₃C₆H₄NNH)P₄}₂(μ-HNNAr-ArNNH)](BPh₄)₄3, 4 derivatives. Binuclear bis(aryldiazenido) [{OsP₄}₂(μ-N₂Ar-ArN₂)](BPh₄)₂ (6) [P=P(OEt)₃; Ar-Ar=4,4^′-C₆H₄-C₆H₄, 4,4^′-C₆H₄-CH₂-C₆H₄] complexes were prepared by deprotonating with NEt₃ the nitrile-diazene [{Os(4-CH₃C₆H₄CN)P₄}₂(μ-HNNAr-ArNNH)](BPh₄)₄ (5) derivatives. The aryldiazenido compounds 6 react with HCl to give the new aryldiazene [{OsClP₄}₂(μ-HNNAr-ArNNH)](BPh₄)₂ (7) derivatives. The characterisation of the complexes by IR and ¹H, ³¹P, ¹⁵N NMR data is also discussed. The reaction of the hydride OsH₂(PPh₂OEt)₄ with mono(diazonium) salts was also studied and led exclusively to the mono(aryldiazene) [OsH(ArN NH)(PPh₂OEt)₄]BPh₄ (8) (Ar=C₆H₅, 4-CH₃C₆H₄) derivatives. Spectroscopic data (¹H, ³¹P, ¹⁵N NMR) on ¹⁵N-labelled derivatives suggest the presence of two isomers with the N-bonded and the π-bonded ArNNH ligand, respectively.     

Synthesis and reactivity of gold(III) complexes containing cycloaurated iminophosphorane ligands

Transmetallation reactions of ortho-mercurated iminophosphoranes (2-ClHgC₆H₄)Ph₂PNR with [AuCl₄]⁻ gives new cycloaurated iminophosphorane complexes of gold(III) (2-Cl₂AuC₆H₄)Ph₂PNR [R = (R,S)- or (S)-CHMePh, p-C₆H₄F, ^tBu], characterised by NMR and IR spectroscopies, ESI mass spectrometry and an X-ray structure determination on the chiral derivative R = (S)-CHMePh. The chloride ligands of these complexes can be readily replaced by the chelating ligands thiosalicylate and catecholate; the resulting derivatives show markedly higher anti-tumour activity versus P388 murine leukaemia cells compared to the parent chloride complexes. Reaction of (2-Cl₂AuC₆H₄)Ph₂PNPh with PPh₃ results in displacement of a chloride ligand giving the cationic complex [(2-Cl(PPh₃)AuC₆H₄)Ph₂PNPh]⁺, indicating that the PN donor is strongly bonded to the gold centre.     

Synthesis, characterization and crystal structure of novel mononuclear peroxotungsten(VI) complexes. Insulinomimetic activity of W(VI) and Nb(V) peroxo complexes

Two new mononuclear peroxo complexes of tungsten of the formula (gu)₂[WO₂(O₂)₂] (1) and (gu)[WO(O₂)₂(quin-2-c)] (2a) (where gu⁺ = guanidinium ion, and quin-2-c = quinoline-2-carboxylate ion) have been synthesized and characterized by elemental analysis, infrared, Raman, UV-visible and ¹H NMR spectroscopies. The crystal structure of (gu)[WO(O₂)₂(quin-2-c)] · H₂O (2b) determined by X-ray diffraction indicates that the side-on peroxo groups and the bidentate quinaldate ligand bind the W(VI) centre leading to an hepta coordination mode. The guanidinium ion occurring as a counterion and the hydrogen-bound interactions stabilize the complexes. The in vitro insulin-mimetic effect of the complexes has been evaluated by the inhibitory effect on free fatty acid release in isolated fat adipocytes treated with epinephrine. Moreover the niobate analogues, synthesized and characterized previously, (gu)₃[Nb(O₂)₄] and (gu)₂[Nb(O₂)₃(quin-2-c)] · H₂O have been tested for the insulin-like activity.     

Synthesis, structures, electrochemistry and properties of dioxo-molybdenum(VI) and -tungsten(VI) complexes with novel asymmetric N2OS, and partially symmetric N2S2, NOS2N-capped tripodal ligands

A new class of asymmetric N-capped (dianionic/trianionic) tripodal proligands [H_x(Lⁿ)] (x = 2, n = 1-6; x = 3, n = 7, 8) which possess pendant arms with N₂OS, N₂S₂ or NOS₂ donor groups and with different chelate ring sizes {5,5,5} or {5,6,5} has been prepared. Treatment of these ligands with [WO₂Cl₂(dme)] (dme = 1,2-dimethoxyethane) in the presence of base (triethylamine or KOH) leads to the formation of cis-dioxotungsten(VI) complexes of the types [WO₂(Lⁿ)] (n = 1-6) and K[WO₂(Lⁿ)] (n = 7, 8). Reaction of these tetradentate ligands with [MoO₂(acac)₂] (acac = acetylacetonate) gives the corresponding Mo(VI) analogues [MoO₂(Lⁿ)] (n = 1-6) and K[MoO₂(Lⁿ)] (n = 7, 8). Moreover, a new five coordinate dioxomolybdenum(VI) complex with an NS₂ tridentate ligand [MoO₂(L⁹)] has been synthesised using similar procedure. All these compounds have been spectroscopically characterised and the molecular structures of [MoO₂(Lⁿ)] (n = 2, 6) and [WO₂(L⁶)] have been established by X-ray diffraction analysis. The electrochemistry and the catalytic activity for oxidation of allylic and benzylic alcohols of these dioxo complexes have also been investigated.     

Synthesis and structural characterization of mixed-ligand silver(I) complexes containing diphosphazanes and bidentate N-donor ligands

The reactions of a self-assembled silver(I) coordination polymer, [Ag₂{μ-PrⁱN(PPh₂)₂}(μ-NO₃)₂]_n (1) with various bidentate N-donor ligands such as DABCO, 2,2′-bipyridyl and 1,10-phenanthroline yield 1-D helices or π-π stacked polymers, depending on the chelate vector of the N-donor ligand. The molecular structures of the resultant complexes, [Ag₂{μ-PrⁱN(PPh₂)₂}(DABCO)(NO₃)₂]_n (2), [Ag₂{μ-PrⁱN(PPh₂)₂}(2,2′-bipy)₂(NO₃)₂] (3) and [Ag₂{μ-PrⁱN(PPh₂)₂}(1,10-phen)₂](NO₃)₂ (4) have been confirmed by single-crystal X-ray diffraction. Complex 2 exists as an infinite helical polymer because of the exo-bidentate nature of DABCO. Complex 3 assumes a 2D grid motif as a result of intermolecular π-π stacking among adjacent bipyridine moieties. The phenanthroline complex 4 exhibits strong inter- and intramolecular π-π stacking interactions.     

Osmadisiloxane and osmastannasiloxane complexes derived from silanolate complexes of osmium(II)

Treatment of the five-coordinate chlorodimethylsilyl complex, Os(SiMe₂Cl)Cl(CO)(PPh₃)₂ with hydroxide readily produces Os(SiMe₂OH)Cl(CO)(PPh₃)₂ (1). Complex 1 is deprotonated by ^tBuLi giving the silanolate complex, Os(SiMe₂OLi)Cl(CO)(PPh₃)₂ (2), which reacts further with Me₃SiCl or Me₃SnCl to give Os(SiMe₂OSiMe₃)Cl(CO)(PPh₃)₂ (3) or Os(SiMe₂OSnMe₃)Cl(CO)(PPh₃)₂ (4), respectively. The structures of 3 and 4 have been determined by X-ray crystallography. Reaction between OsH(κ²-S₂CNMe₂)(CO)(PPh₃)₂ and HSiMe₂Cl gives Os(SiMe₂Cl)(κ²-S₂CNMe₂)(CO)(PPh₃)₂ (5). This six-coordinate chlorodimethylsilyl complex, is unreactive towards hydroxide at room temperature and at 60 °C forms Os[Si(OH)₃](κ²-S₂CNMe₂)(CO)(PPh₃)₂ (7). Complex 5 is, however, smoothly converted to the hydroxy derivative, Os(SiMe₂OH)(κ²-S₂CNMe₂)(CO)(PPh₃)₂ (6) upon chromatography on silica gel. Complex 6 is deprotonated by ^tBuLi giving the intermediate silanolate complex, Os(SiMe₂OLi)(κ²-S₂CNMe₂)(CO)(PPh₃)₂, which reacts further with Me₃SiCl to give Os(SiMe₂OSiMe₃)(κ²-S₂CNMe₂) (CO)(PPh₃)₂ (8). Crystal structure determinations for 5, 6, 7, and 8 have been obtained and structural comparisons of these related compounds are made.     

Cr(VI) reduction by Enterobacter sp. DU17 isolated from the tannery waste dump site and characterization of the bacterium and the Cr(VI) reductase

Out of nineteen bacteria screened from the tannery waste dump site, the most effective isolate, strain DU17 was selected for Cr(VI) reduction process among the non-pathogenic once. Based on 16S rRNA gene sequence analysis, the bacterium was identified as Enterobacter sp. DU17. Its amplified Cr(VI) reductase gene showed maximum homology with flavoprotein of Enterobacter cloacae. Enterobacter sp. DU17 reduced Cr(VI) maximally at 37 °C and pH 7.0. Various co-metals, electron (e⁻) donors and inhibitors were tested to study their effect on Cr(VI) reduction. In presence (0.2% each) of glucose and fructose, Enterobacter sp. DU17 reduced Cr(VI) completely after 16 and 20 h, respectively. Since the concentration of total Cr was invariable after remediation as detected through AAS analysis, this experiment disclosed that responsible operation was associated with extracellular Cr(VI) reduction process rather than uptake mechanism. Multiple antibiotic resistance index of 0.08 for this bacterium was very low as compared to standard risk assessment value of 0.20. With high Cr(VI) reducing capability, non-pathogenicity and antibiotic sensitivity, Enterobacter sp. DU17 is found to be very efficient in removing Cr(VI) toxicity from the environment.     

Three Mn(II) supramolecular coordination complexes containing carboxylate-tetrazolate ligands

Three novel complexes [Mn(atza)₂(H₂O)₄] (1), [Mn(nptza)₂(CH₃OH)₄] (2), and [Mn(a4-ptz)₂(H₂O)₂]_n · 2nH₂O] (3) [atza = 5-aminotetrazole-1-acetato, nptza = 5-[(4-nitryl)phenyl] tetrazole-1-acetato, a4-ptz = 5-[N-acetato(4-pyridyl)] tetrazole] containing carboxylate-tetrazolate ligands have been synthesized and characterized by element analysis. X-ray crystallography shows that complexes 1 and 2 both contain mononuclear structure. The complex 3 is a 1D polymeric chain structure. Compounds 1-3 are self-assembled to form supramolecular structures through hydrogen bonds interactions.     

Zinc(II) complexes based on sterically hindered hydrotris(pyrazolyl)borate ligands: Synthesis, reactivity and solid-state structures

The coordination chemistry and reactivity of zinc(II) complexes supported by monoanionic hydrotris(pyrazolyl)borate ligands substituted by 3,3,3-mesityl groups (Tp^Ms) and 3,3,5-mesityl groups (Tp^Ms∗) have been investigated. Salt metathesis of ZnCl₂, ZnEt₂, and Zn(OAc)₂ with Tl[Tp^Ms] or Tl[Tp^Ms∗] cleanly afforded the corresponding compounds Tp^MsZnCl (1), Tp^MsZnEt (2), Tp^Ms∗ZnEt (3), and Tp^MsZnOAc (5). Compound 3 slowly disproportionates in benzene solution to afford the bis(ligand) complex (κ²-Tp^Ms∗)₂Zn (4). Acetate complex 5 as well as Tp^MsZnOCOPh (6) and [Tp^Ms∗ZnOAc]₂ (7) were alternatively prepared by acidolysis of the parent ethyl complexes (2, 3) with the corresponding carboxylic acid. No reaction was observed between 2 and 3 and alcohols (ROH; R = Et, iPr, Bn), while salt metathesis reactions of ZnEt(OR) with Tl[Tp^Ms] led to 2 instead of the desired zinc-alkoxide complex. Compounds 1-7 were characterized by elemental analysis, ¹H and ¹³C NMR spectroscopy, as well as by X-ray diffraction studies for 1, 2, 4, 5 and 7. The former compounds adopt a monomeric structure in the solid state while [Tp^Ms∗ZnOAc]₂ (7) exists as an anti-syn bridged acetate dimer. Complex 4 is four-coordinated, featuring a rare bidentate coordination mode of the Tp^Ms∗ ligands. The results are rationalized in terms of the variable steric constraint around the zinc atom provided by the Tp^Ms and Tp^Ms∗ ligands.     

微生物还原Cr(VI)的研究进展

随着现代工业的发展, 水环境中的重金属对人类健康和环境带来严重的危害, 其中的Cr(VI)具有强烈的毒性。微生物在代谢过程中可以将Cr(VI)还原为Cr(III), 有效降低Cr(VI)的毒性。本文从可还原Cr(VI)的微生物、微生物还原Cr(VI)的机理、还原过程中存在的问题及发展方向等方面进行了综述。     

木霉生物吸附重金属铬机理的研究

利用木霉（Trichoderma lhd）菌体作为吸附剂,对水体中的六价铬进行生物吸附,借助傅立叶红外变换光谱和拉曼光谱对六价铬的生物吸附机理进行了探讨。实验条件优化结果表明,温度28 ℃以及酸性环境条件（pH 1）有利于Cr （VI） 的生物吸附,12小时内,Cr （VI） 的生物吸附去除效率达99 %。吸附机理实验结果分析表明,相比于对照实验,2350 cm^-1吸收峰的出现为吸附剂表面质子化的氨基如＞NH2^＋, NH^＋, ＞C=NH^＋―等基团吸附Cr （VI）所致。拉曼光谱中吸收峰2097 cm^-1强度显著增强进一步表明,Cr （VI）的生物吸附是吸附剂表面氨基基团在起作用。     

微生物还原Cr(VI)的研究进展

随着现代工业的发展,水环境中的重金属对人类健康和环境带来严重的危害,其中的Cr(VI)具有强烈的毒性.微生物在代谢过程中可以将Cr(VI)还原为Cr(Ⅲ),有效降低Cr(VI)的毒性.本文从可还原Cr(VI)的微生物、微生物还原Cr(VI)的机理、还原过程中存在的问题及发展方向等方面进行了综述.     

Synthesis and characterization of ruthenium and osmium complexes of heterocyclic bidentate ligands (N, X), X = S, Se

The reaction of [RuCl₂(PPh₃)₃] and [OsBr₂(PPh₃)₃] precursors with a series of heterocyclic bidentate (N, X) ligands, X = S, Se, gave complexes [M(R-pyS)₂(PPh₃)₂], (R = H, 3-CF₃, 5-CF₃, 3-Me₃Si); [M(R-pymS)₂(PPh₃)₂], (R = 4-CF₃, 4,6-MeCF₃) and [M(R-pySe)₂(PPh₃)₂], (R = H, 3-CF₃, 5-CF₃), where M is Ru or Os, pyS and pymS the anions of pyridine-2-thione and pyrimidine-2-thione, respectively, and pySe is the anion produced by the reductive cleavage of the Se-Se bond in the dipyridyl-2,2′-diselenide. All of the compounds obtained were characterized by microanalysis, IR, FAB, NMR spectroscopy and by cyclic voltammetry. Compounds [Ru(3-CF₃-pyS)₂(PPh₃)₂] · 2(CH₂Cl₂) (2), [Ru(3-Me₃Si-pyS)₂(PPh₃)₂] (4), [Ru(4-CF₃-pymS)₂(PPh₃)₂] (5), [Ru(3-CF₃-pySe)₂(PPh₃)₂] · 2(CH₂Cl₂) (8), [Os(3-CF₃-pyS)₂(PPh₃)₂] · (CHCl₃) (11), [Os(3-Me₃Si-pyS)₂(PPh₃)₂] (13), [Os(3-CF₃-pySe)₂(PPh₃)₂] · 2(CH₂Cl₂) (17), [Os(5-CF₃-pySe)₂(PPh₃)₂] · 2(H₂O) (18) and [OsCl₂(4,6-MeCF₃-pymS)(PPh₃)₂] (19) were also characterized by X-ray diffraction. In all cases, the metal is in a distorted octahedral environment with the heterocyclic ligand acting as a bidentate (N, S) chelate system.     

Effect of complexing agents on reduction of Cr(VI) by Desulfovibrio vulgaris ATCC 29579

The reduction of Cr(VI) at the expense of molecular hydrogen was studied using resting cells of Desulfovibrio vulgaris ATCC 29579 in anaerobic resting cell suspensions in MOPS buffer. Bioreduction occurred only in the presence of ligands or chelating agents (CO32-, citrate, NTA, EDTA, DTPA). The stimulatory effect of these ligands on the rate of Cr(VI) reduction was correlated (r = 0.988) with the strength of the ligand/chelate complex of Cr(III). The data are examined with respect to likely solution and redox equilibria in the ionic matrix of the carrier solution, and with respect to the potential for bioremediation of Cr(VI).